Clinical Trial Update: Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell Line [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combined effects of Licochalcone A and Paclitaxel on an oral squamous cell carcinoma cell line, sponsored by Cairo University. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Squamous Cell Carcinoma

Drugs mentioned

• Licochalcone A (Licochalcone A)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Cairo University | Conditions: Squamous Cell Carcinoma | Phase 1 | Status: COMPLETED